THE DATA ON APPEAL SUCCESS
How Often Do Insurance Appeals Succeed?
The Short Answer: Appeals Are Worth It
Appeal success rates range from 44% to over 80% depending on your insurance type and appeal level—yet less than 1% of denied patients ever file an appeal.[1][2]
If you've been denied coverage for Wegovy, the data supports appealing. Here's what the research shows—with important context about which numbers apply to which insurance types:
| Appeal Type | Population | Success Rate | Source |
|---|---|---|---|
| Internal Appeals | ACA Marketplace (Commercial) | 44% | KFF (2023) |
| Prior Auth Appeals | Medicare Advantage | 80–83% | KFF/CMS (2023) |
| External Reviews | State Average (All Plans) | 50–65% | State DOI Reports |
| External Reviews | California (All Plans) | 60–80% | CA DMHC |
Understanding the Numbers
The 80%+ figure comes from Medicare Advantage prior authorization data. For commercial/employer insurance (most Wegovy patients), the ACA Marketplace data showing 44% internal appeal success is more relevant. External reviews consistently show 50–65%+ success across all insurance types.
Sources: KFF,[2] AMA,[1] State Department of Insurance Reports[3]
Why Are Success Rates So High?
Initial denials are often automated or incomplete
Many denials happen because documentation was missing, not because you don't qualify. Algorithms and quick reviews miss context that a human reviewer—or your doctor—can provide during an appeal.
Appeals trigger actual physician review
When you appeal, a licensed physician reviews your case—not just an algorithm. California's SB 1120 now requires this by law. When doctors review other doctors' recommendations, they're more likely to approve.
Appeals allow you to add missing information
Your initial prior authorization may have been missing key documentation—recent BMI (body mass index, a measure of weight relative to height), comorbidity (related medical condition) diagnoses, or records of prior weight loss attempts. An appeal lets you fill in those gaps.
A Note About Wegovy & GLP-1 Data
There's no publicly available "Wegovy-only" appeal success dataset. The 80%+ figure is specifically from Medicare Advantage prior authorization appeals—and basic Medicare Part D coverage excludes weight-loss drugs (the separate Medicare GLP-1 Bridge runs outside Part D). For most Wegovy patients with commercial insurance, the 44% internal appeal rate (ACA Marketplace) is a more conservative, applicable benchmark. External reviews (50–65%+) are relevant across all insurance types.
SUCCESS RATES AND DIFFERENCES
Internal vs External Appeals
There are two levels of appeals you can pursue. Understanding the difference—and the success rates of each—helps you know what to expect.
| Factor | Internal Appeal | External Review |
|---|---|---|
| Who Reviews | Your insurance company | Independent reviewer (not employed by insurer) |
| Success Rate | 44% (commercial); 80%+ (MA) | 50–65%+ (all plans) |
| Timeline | 30 days for services not yet received; 60 days for services already received | 45 days (72 hours if urgent) |
| Deadline to File | 180 days from denial | 4 months after internal denial |
| Decision Binding? | No—you can escalate | Yes—insurer must comply |
Internal Appeals: Your First Step
When you file an internal appeal, your insurance company reviews the denial again. According to KFF, 44% of internal appeals in ACA marketplace (commercial) plans succeed.[2] Medicare Advantage prior authorization appeals show higher rates (80%+), but this data is less applicable to most Wegovy patients since basic Medicare Part D coverage excludes weight-loss drugs.[1]
- Timeline: Insurers must decide within 30 days for services not yet received; 60 days for services already received
- Urgent cases: 72-hour expedited review available
- If denied: You can escalate to external review
External Reviews: The Final (and Most Powerful) Step
If your internal appeal is denied, you have the right to an external review by an independent organization not employed by your insurer. This is your most powerful tool.
External Review Success by State
Key advantage: External review decisions are binding on your insurance company. If the independent reviewer says "cover it," your insurer must comply.
Your GLP-1 coverage,
denied approved
Honest Care writes personalized, evidence-backed appeal letters — so you can fight back with confidence.
Need help with your appeal?
Get Started FreeTHE APPEAL GAP (AND WHY YOU SHOULD)
Why So Many People Never Appeal
The Shocking Reality
Less than 1% of denied claims are ever appealed—despite success rates ranging from 44% (commercial internal) to 65%+ (external review). Insurers count on people giving up.[6]
The numbers are staggering. Of the millions of claims denied each year:
Data: KFF Claims Denials and Appeals Report (2023),[2] AMA Prior Authorization Survey[1]
Why Don't People Appeal?
| Reason | Percentage |
|---|---|
| Don't know they have the right to appeal | 69% |
| Don't believe it will work (based on perception, not data) | 62% |
| Patient care can't wait | 48% |
| Insufficient time or resources | 48% |
| Process seems too complicated | 45% |
Sources: AMA Prior Authorization Survey,[1] KFF Consumer Survey[7]
Why You Should Appeal Anyway
The Case for Appealing
- You have nothing to lose—appeals are free
- Success rates are meaningful (44%+ internal, 50–65%+ external)
- It's your legal right under the ACA
- External reviews are binding on insurers
- Templates and services make it easier than ever
The AMA highlights that most prior authorization appeals succeed—yet hardly anyone appeals.[1] While the 80%+ figure in their headline applies to Medicare Advantage, the core point holds: appeals work, and the vast majority of patients who could benefit from appealing never try.
FACTORS THAT IMPROVE SUCCESS
What Increases Your Chances of Winning?
While success rates are high overall, certain factors significantly improve your odds:
Get Your Doctor Involved
Physician support is the #1 factor in successful appeals. When your doctor writes a Letter of Medical Necessity or participates in a peer-to-peer review (a direct call with the insurance company's medical director), approval rates increase significantly. Insurers are more likely to approve when a licensed physician advocates for the treatment.
Complete Documentation
Many denials happen because documentation was missing or incomplete. Your appeal should include:
- Current BMI (body mass index, documented within last 30 days)
- Comorbidity (related medical condition) diagnoses with ICD-10 codes
- Prior weight loss attempts (diet, exercise, medications)
- Lab results (A1C, lipid panel, etc.)
- Medical history supporting medical necessity
Address the Specific Denial Reason
Generic appeals are less effective. Your appeal should directly counter the exact reason stated in your denial letter. If they said "not medically necessary," cite clinical evidence. If they said "step therapy required," document prior treatments or request an exception.
Cite Clinical Evidence
Include data from clinical trials (like STEP 1 showing 15% weight loss at 68 weeks) and professional guidelines (AACE, Endocrine Society). Objective evidence is harder to dismiss than general arguments.
Use Templates and Professional Help
Appeal letters that follow proven formats with all required elements are more likely to succeed. Services like Honest Care provide evidence-backed templates and specialist-written appeals specifically designed for GLP-1 medications.
The Peer-to-Peer Review Option
Your doctor can request a peer-to-peer review—a direct conversation with the insurance company's medical director. This often resolves denials quickly because it's doctor-to-doctor, bypassing bureaucratic processes. Ask your provider if they offer this.
GETTING HELP WITH YOUR APPEAL
How Honest Care Fits Into the Appeal Picture
Appealing an insurance denial can feel overwhelming—but you don't have to do it alone. Honest Care specializes in helping patients appeal GLP-1 medication denials like Wegovy.
What Honest Care Provides
- Free appeal letter templates — Get started at no cost
- Premium specialist-written appeals ($79) — Personalized, evidence-backed letters
- Consultation packages ($139) — One-on-one guidance through the process
- Step-by-step submission tools — Makes filing your appeal simple
Our appeal letters are designed specifically for GLP-1 medications and include:
- Clinical evidence from STEP trials
- Counter-arguments for common denial reasons
- Proper formatting and required elements
- Citations to FDA approval and professional guidelines
Every patient has the legal right to appeal. With Honest Care, it's easier than ever to fight for the coverage you deserve.
WEGOVY APPEAL SUCCESS
Frequently Asked Questions
There's no Wegovy-specific public dataset. For commercial insurance (most Wegovy patients), internal appeals succeed about 44% of the time (KFF, ACA Marketplace data). External reviews overturn denials 50–65%+ of the time depending on the state. The 80%+ figure often cited is specifically from Medicare Advantage prior auth data, which is less applicable since basic Medicare Part D coverage excludes weight-loss drugs.
Yes—the data shows appeals are effective. For commercial insurance, internal appeals succeed around 44% of the time, and external reviews succeed 50–65%+ of the time. The key is providing complete documentation, getting your doctor involved, and addressing the specific denial reason. External reviews, where an independent reviewer evaluates your case, are particularly effective and binding.
GLP-1 medication appeals follow similar patterns to other prior authorization appeals. For commercial insurance, success rates range from 44% (internal appeals) to 50–65%+ (external reviews). Key factors include physician involvement, complete documentation, and citing clinical evidence from trials like STEP 1.
Internal appeals are reviewed by your insurance company. They must respond within 30 days for services not yet received; 60 days for services already received, and you have 180 days to file. Success rate: ~44% for commercial plans. External reviews are conducted by independent reviewers not employed by your insurer, must be decided within 45 days, and the decision is binding—your insurer must comply. Success rate: 50–65%+.
Shockingly few: less than 1% of denied claims are ever appealed. According to KFF, only 0.2% of denied claims go through an internal appeal process. This is despite meaningful success rates (44% internal, 50–65%+ external). Most people don't appeal because they don't know they can, assume it won't work, or find the process intimidating.
For internal appeals: 180 days from the denial date for most commercial insurance. For external reviews: 4 months after your internal appeal is denied (some states allow longer). Check your denial letter for your specific deadline.
The top factors are: (1) Physician involvement—having your doctor write a Letter of Medical Necessity or do a peer-to-peer review; (2) Complete documentation—current BMI, comorbidity diagnoses, prior treatment records; (3) Addressing the specific denial reason; (4) Clinical evidence—citing trial data and guidelines.
Yes. Appeals are free, success rates are meaningful (44% internal, 50–65%+ external for commercial insurance), and you have nothing to lose. Even if your internal appeal is denied, you can escalate to external review, which has higher success rates and is binding on your insurer.
YOUR PATH FORWARD
What's Next
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get startedWHAT'S CHANGING
2026 Outlook: Will Appeal Rates Improve?
2026: Regulatory Changes May Impact Success Rates
The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) took effect in 2026: From January 1, 2026, Medicare Advantage, Medicaid and CHIP must decide medical prior authorizations within 7 days (72 hours if urgent); the rule excludes drugs. Because it excludes drugs, it doesn't directly change GLP-1 prescription prior authorizations.
State-Level Reform Trends
Several states are strengthening patient protections for 2026:
- California SB 1120: Requires physician review of denials (not algorithms), which has been linked to higher approval rates
- Texas "Gold Carding": Providers with 90%+ approval rates bypass PA entirely
- Multiple states: Pending legislation to limit step therapy for weight loss medications
These reforms may improve first-time approval rates, reducing the need for appeals.
Employer Coverage Expanding
More employers are adding GLP-1 coverage for 2026 (estimated 25%+ of large employers, up from 19% in 2024). This means:
- More patients with coverage = fewer formulary exclusion denials
- But stricter PA requirements as employers manage costs
- New weight management program enrollment requirements in some plans
Check your 2026 plan options during open enrollment (November–January).
Oral Wegovy: A New Option
Novo Nordisk launched oral semaglutide for weight loss (oral Wegovy) in late 2025:
- Daily pill instead of weekly injection
- May have different prior authorization requirements
- Expected to be added to formularies throughout 2026
See our Oral Wegovy Guide for coverage details.
References
- American Medical Association. (2023). "Over 80% of Prior Auth Appeals Succeed—Why Aren't There More?" ama-assn.org
- Kaiser Family Foundation. (2024). "Claims Denials and Appeals in ACA Marketplace Plans in 2023." kff.org
- Pennsylvania Insurance Department. (2024). "Pennsylvania's Independent External Review Process Proves to be a Valuable Resource." pa.gov
- National Nurses United. (2024). "60-80% of Insurance Denials Overturned or Reversed When Taken to Independent Medical Review." nationalnursesunited.org
- Counterforce Health. (2025). "State by State Guide to New Insurance Appeal Laws." counterforcehealth.org
- Counterforce Health. (2024). "Insurance Denial Statistics: Why 80% of Appeals Succeed (But Only 1% Try)." counterforcehealth.org
- Kaiser Family Foundation. (2024). "Medicare Advantage Insurers Made Nearly 50 Million Prior Authorization Determinations in 2023." kff.org
- HealthCare.gov. "Internal Appeals." healthcare.gov
- HealthCare.gov. "External Review." healthcare.gov
- Centers for Medicare & Medicaid Services. "Internal Claims and Appeals and the External Review Process Overview." cms.gov
- Commonwealth Fund. (2024). "More Medicare Advantage Beneficiaries Are Filing Appeals for Denied Services or Treatments." commonwealthfund.org
Last updated October 6, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.